NCT01491867View on ClinicalTrials.gov

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

travoprost 0.003%

Instillation of travoprost 0.003% 1/die in both eyes for 3 months

Trial Locations (2)

1083

Departement of Ophthalmology, Budapest

Semmelweis University, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER

NCT01491867 - Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect | Biotech Hunter | Biotech Hunter